Translational Neurodegeneration : Impact Factor & More
eISSN: 2047-9158pISSN: 2047-9158
Open AccessShare this on:
Key Metrics
CiteScore 
12
Impact Factor
10 - 15
SJR
Q1Neurology (clinical)
SNIP
1.76
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Translational Neurodegeneration
Translational Neurodegeneration Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2490 | USD 2890 | GBP 2090 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in Translational Neurodegeneration ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Translational Neurodegeneration
N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's disease
- 27 Apr 2026
- Translational Neurodegeneration
The Drp1-CoQ10-Coa6-ETC axis represents a therapeutic potential for working memory impairment caused by neuronal mitochondrial dysfunction.
- 27 Apr 2026
- Translational neurodegeneration
Dysfunction of the neurovascular unit as a temporal driver in Alzheimer's pathogenesis.
- 22 Apr 2026
- Translational neurodegeneration
NDST3 suppression restores lysosomal acidification and ameliorates amyloid-β and MAPT/tau pathology in Alzheimer's disease.
- 21 Apr 2026
- Translational neurodegeneration
Drug repurposing for disease-modifying effects in multiple system atrophy.
- 21 Apr 2026
- Translational neurodegeneration
Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy.
- 25 Mar 2026
- Translational neurodegeneration
N-terminally acetylated Met11-Tau: a new pathological truncated Tau species with functional relevance in Alzheimer's disease
- 27 Apr 2026
- Translational Neurodegeneration
The Drp1-CoQ10-Coa6-ETC axis represents a therapeutic potential for working memory impairment caused by neuronal mitochondrial dysfunction.
- 27 Apr 2026
- Translational neurodegeneration
Dysfunction of the neurovascular unit as a temporal driver in Alzheimer's pathogenesis.
- 22 Apr 2026
- Translational neurodegeneration
NDST3 suppression restores lysosomal acidification and ameliorates amyloid-β and MAPT/tau pathology in Alzheimer's disease.
- 21 Apr 2026
- Translational neurodegeneration
Drug repurposing for disease-modifying effects in multiple system atrophy.
- 21 Apr 2026
- Translational neurodegeneration
Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy.
- 25 Mar 2026
- Translational neurodegeneration
FAQs on Translational Neurodegeneration
How long has Translational Neurodegeneration been actively publishing? 
What is the publishing frequency of Translational Neurodegeneration?
How many articles did Translational Neurodegeneration publish last year?
What is the eISSN & pISSN for Translational Neurodegeneration?
What is Citescore for Translational Neurodegeneration?
What is SNIP score for Translational Neurodegeneration?
What is the SJR for Translational Neurodegeneration?
Who is the publisher of Translational Neurodegeneration?
